Back to Search
ERNEST DEJESUS, MD
MD
Nephrology Physician
NPI: 1295737088Individual
Specialties, Licenses & Credentials
Nephrology PhysicianPrimary
Internal Medicine — Nephrology
Code: 207RN0300X
036.109525(IL)
Education
OHIO STATE UNIVERSITY COLLEGE OF MEDICINE
Class of 2000
Research & Publications (20)
Fosamprenavir or atazanavir once daily boosted with ritonavir 100 mg, plus tenofovir/emtricitabine, for the initial treatment of HIV infection: 48-week results of ALERT.
PMID 18373851·AIDS Res Ther·2008
8-other
Safety and efficacy of enfuvirtide in combination with darunavir-ritonavir and an optimized background regimen in treatment-experienced human immunodeficiency virus-infected patients: the below the level of quantification study.
PMID 18809940·Antimicrob Agents Chemother·2008
3-trial
Safety, pharmacokinetics, and antiretroviral activity of multiple doses of ibalizumab (formerly TNX-355), an anti-CD4 monoclonal antibody, in human immunodeficiency virus type 1-infected adults.
PMID 19015347·Antimicrob Agents Chemother·2009
2-rct
Comparison of once-daily fosamprenavir boosted with either 100 or 200 mg of ritonavir, in combination with abacavir/lamivudine: 96-week results from COL100758.
PMID 19320570·AIDS Res Hum Retroviruses·2009
4-observational
A randomized, controlled trial of initial anti-retroviral therapy with abacavir/lamivudine/zidovudine twice-daily compared to atazanavir once-daily with lamivudine/zidovudine twice-daily in HIV-infected patients over 48 weeks (ESS100327, the ACTION Study).
PMID 19358725·AIDS Res Ther·2009
8-other
Simplification of antiretroviral therapy to a single-tablet regimen consisting of efavirenz, emtricitabine, and tenofovir disoproxil fumarate versus unmodified antiretroviral therapy in virologically suppressed HIV-1-infected patients.
PMID 19357529·J Acquir Immune Defic Syndr·2009
4-observational
Proof of activity with AMD11070, an orally bioavailable inhibitor of CXCR4-tropic HIV type 1.
PMID 19193109·Clin Infect Dis·2009
3-trial
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial.
PMID 19647866·Lancet·2009
3-trial
Modulation of K65R selection by zidovudine inclusion: analysis of HIV resistance selection in subjects with virologic failure receiving once-daily abacavir/lamivudine/zidovudine and tenofovir DF (study COL40263).
PMID 19563238·AIDS Res Hum Retroviruses·2009
3-trial
Select updates from the 16th CROI: treatment-related cardiovascular risk, pharmacokinetic issues, and interleukin-2 use.
PMID 19388184·AIDS Read·2009
8-other
Antiretroviral therapy update from the 48th ICAAC/46th IDSA annual meeting.
PMID 19209453·AIDS Read·2009
8-other
Maraviroc for previously treated patients with R5 HIV-1 infection.
PMID 18832244·N Engl J Med·2008
3-trial
The 3-year renal safety of a tenofovir disoproxil fumarate vs. a thymidine analogue-containing regimen in antiretroviral-naive patients.
PMID 18832879·AIDS·2008
3-trial
First large, multicenter, open-label study utilizing HLA-B*5701 screening for abacavir hypersensitivity in North America.
PMID 18670229·AIDS·2008
3-trial
Efficacy and safety of once-daily darunavir/ritonavir versus lopinavir/ritonavir in treatment-naive HIV-1-infected patients at week 48.
PMID 18614861·AIDS·2008
3-trial
Adherence to enfuvirtide and its impact on treatment efficacy.
PMID 18240965·AIDS Res Hum Retroviruses·2008
4-observational
Safety, pharmacokinetics, and antiviral activity of HGS004, a novel fully human IgG4 monoclonal antibody against CCR5, in HIV-1-infected patients.
PMID 18266604·J Infect Dis·2008
3-trial
Antiretroviral treatment update from the 17th International AIDS Conference.
PMID 19062402·AIDS Read·2008
8-other
Tenofovir disoproxil fumarate, emtricitabine, and efavirenz compared with zidovudine/lamivudine and efavirenz in treatment-naive patients: 144-week analysis.
PMID 17971715·J Acquir Immune Defic Syndr·2008
2-rct
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 302 Randall Rd
Geneva, IL 60134 - Phone
- (630) 690-1220
Quick Facts
- NPI
- 1295737088
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 26
- Publications
- 20
Are you this provider?
Claim Your Profile